Resverlogix resverlogix.com


Resverlogix is a clinical biotechnology company that aims to improve and save the lives of patients with high-risk cardiovascular disease, diabetes mellitus, and chronic kidney disease.

Resverlogix is a clinical biotechnology company that aims to improve and save the lives of patients with high-risk cardiovascular disease, diabetes mellitus, and chronic kidney disease.

Company (IPO / Went public)

Phone: 403.254.9252

Fax:

300, 4820 Richard Road SW

 Calgary, T3E 6L1
 Alberta, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Resverlogix $11.3M Apr 1, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Resverlogix Jobs

jobs by Indeed job search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Compositions and therapeutic methods for the treatment of complement-associated diseases Sep 26, 2018 Sep 15, 2020 Patent
Compounds for the prevention and treatment of cardiovascular diseases Sep 20, 2017 Jan 14, 2020 Patent
Novel anti-inflammatory agents Nov 16, 2015 Nov 20, 2018 Patent
Compositions and therapeutic methods for the treatment of complement-associated diseases Mar 10, 2016 Oct 30, 2018 Patent
Pharmaceutical compositions for substituted quinazolinones Jan 18, 2017 Jul 10, 2018 Patent
See all 22 patents